Kala Bio (KALA) Research & Development (2016 - 2026)

Kala Bio has disclosed Research & Development across 11 years of filings, most recently posting $59000.0 for Q2 2026.

• In Q2 2026, Research & Development fell 99.05% year-over-year to $59000.0; the TTM figure through Jun 2026 stood at $6.6 million (down 70.88% YoY), while the FY2025 annual figure was $18.8 million, down 15.0% from the prior year.
• Research & Development came in at $59000.0 for Q2 2026 at Kala Bio, down from $61000.0 in the prior quarter.
• In the past five years, Research & Development ranged from a high of $6.4 million in Q1 2024 to a low of $59000.0 in Q2 2026.
• Average Research & Development over 5 years is $4.3 million, with a median of $4.9 million recorded in 2023.
• Year-over-year, Research & Development soared 87.12% in 2022 and plunged 99.05% in 2026.
• Over 5 years, Research & Development stood at $3.3 million in 2022, then soared by 41.98% to $4.7 million in 2023, then climbed by 11.45% to $5.3 million in 2024, then tumbled by 93.04% to $366000.0 in 2025, then slumped by 83.88% to $59000.0 in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $59000.0 in Q2 2026, $61000.0 in Q1 2026, and $366000.0 in Q4 2025.